Provided by Tiger Fintech (Singapore) Pte. Ltd.

Astria Therapeutics Inc

5.57
+0.13002.39%
Post-market: 5.570.00000.00%19:30 EDT
Volume:1.35M
Turnover:7.54M
Market Cap:314.34M
PE:-2.97
High:5.64
Open:5.44
Low:5.41
Close:5.44
Loading ...
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 12, 2023

Major Issues Report

Form 8-K - Current report
Oct 12, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

Correspondence

Form CORRESP - Correspondence
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 22, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2023

Major Issues Report

8-K - Current report